DelveInsight has launched a new report on Frontotemporal Dementia Epidemiology Forecast to 2030
DelveInsight’s ‘Frontotemporal Dementia – Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Frontotemporal Dementia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Frontotemporal dementia (FTD) is an umbrella term for a diverse group of uncommon disorders that primarily affect the frontal and temporal lobes of the brain areas. In this disorder, portions of these lobes shrink (atrophy). The degeneration of frontotemporal lobe is primarily triggered due to proteins involvement TDP43 and tau, which directly outbreaks the damage on the temporal and frontal lobes of the brain.
Request for :- free sample page
The Frontotemporal Dementia epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Frontotemporal Dementia epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Frontotemporal Dementia epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
The Frontotemporal Dementia epidemiology covered in the report provides historical as well as forecasted Frontotemporal Dementia epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.
The DelveInsight Frontotemporal Dementia report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
Key companies are working on this disease that are given below:-
1. TauRX Therapeutics
2. Alector Pharma Co.
Name of drugs covered that are given below:-
Table of contents
1. Key Insights
2. Executive Summary of Frontotemporal Dementia
3. Frontotemporal Dementia: Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Frontotemporal Dementia Treatment and Management
6.2. Frontotemporal Dementia Treatment Algorithm
7. KOL Views
8. Unmet Needs
9.2. Report Methodology
10. DelveInsight Capabilities
12. About DelveInsight
Why should you buy this report?
- The Frontotemporal Dementia Epidemiology report will allow the user to –
- Develop business strategies by understanding the trends shaping and driving the global Frontotemporal Dementia market
- Quantify patient populations in the global Frontotemporal Dementia market to improve product design, pricing, and launch plans
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Frontotemporal Dementia therapeutics in each of the markets covered
- Understand the magnitude of Frontotemporal Dementia population by its epidemiology
- The Frontotemporal Dementia Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States